NFKBIA and cancer: As reported in previous studies, upregulated caspase-3 inhibits IKK2 (20,21) in necrotized or apoptotic cancer cells, resulting in a further reduction in the phosphorylation of IκBα, causing the NF-κBp65 level to be further reduced.